by winston » Mon Feb 15, 2021 1:42 pm
not vested
SATS Ltd (SATS SP) - Boost from strong cargo demand
SATS’s results came in within our expectations.
3QFY21 revenue fell 54% YoY to SGD251.0m while PATMI loss narrowed from SGD33.2m last quarter to a loss of SGD2.8m in 3QFY21, thanks to strong cargo performance and government relief.
Management shared that SATS has handled inbound and transhipment of Covid-19 vaccine shipments across Asia.
With the rollout of vaccines, we believe that SATS is poised to benefit from vaccine shipment as a Certified pharma handler and a gradual recovery of travel demand ahead.
As it may take time for global rollout of vaccines and opening of international borders, we believe that SATS may have to rely on its non-aviation (17%/44% of FY20/9MFY21 revenue) segment and cargo services to support its revenue growth in the near to mid-term.
After adjustments, our fair value estimate increases from SGD4.31 to SGD4.95. BUY.
Source: OCBC
It's all about "how much you made when you were right" & "how little you lost when you were wrong"